Legend Biotech Corporation

0.71 (1.04%)


Draw Mode:

Volume 442,173
Bid Price 68.00
Ask Price 70.53
News -
Company Name Stock Ticker Symbol Market Type
Legend Biotech Corporation LEGN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.71 1.04% 68.91 20:00:00
Open Price Low Price High Price Close Price Prev Close
68.00 67.67 69.81 68.91 68.20
Trades Volume VWAP Dollar Volume Avg Volume
8,870 442,173  68.85  30,443,546 -
Last Trade Time Type Quantity Stock Price Currency
17:29:34 5  68.01 USD

Legend Biotech Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 11.37B 165.07M 163.19M  116.68M  -4.36M -1.40 -2,606.71
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - - - -

more financials information »

News Legend Biotech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No LEGN Message Board. Create One! See More Posts on LEGN Message Board See More Message Board Posts

LEGN Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.
6 Months0.
1 Year0.
3 Years0.
5 Years0.

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from North America.